JP Morgan Chase’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $359K | Sell |
21,122
-125,149
| -86% | -$2.51M | ﹤0.01% | 5203 |
|
|
2025
Q4 | $3.43M | Sell |
146,271
-388,274
| -73% | -$8.42M | ﹤0.01% | 3659 |
|
|
2025
Q3 | $10.7M | Buy |
534,545
+144,181
| +37% | +$2.59M | ﹤0.01% | 2656 |
|
|
2025
Q2 | $5.35M | Buy |
390,364
+19,405
| +5% | +$186K | ﹤0.01% | 3103 |
|
|
2025
Q1 | $4.1M | Buy |
370,959
+349,845
| +1,657% | +$3.73M | ﹤0.01% | 3332 |
|
|
2024
Q4 | $225K | Sell |
21,114
-46,948
| -69% | -$562K | ﹤0.01% | 5425 |
|
|
2024
Q3 | $864K | Buy |
68,062
+49,318
| +263% | +$732K | ﹤0.01% | 4561 |
|
|
2024
Q2 | $315K | Buy |
18,744
+1,078
| +6% | +$15.3K | ﹤0.01% | 4918 |
|
|
2024
Q1 | $265K | Sell |
17,666
-6,278
| -26% | -$103K | ﹤0.01% | 5188 |
|
|
2023
Q4 | $359K | Buy |
23,944
+4,901
| +26% | +$63.6K | ﹤0.01% | 5001 |
|
|
2023
Q3 | $267K | Sell |
19,043
-32,174
| -63% | -$516K | ﹤0.01% | 4875 |
|
|
2023
Q2 | $530K | Sell |
51,217
-9,174
| -15% | -$101K | ﹤0.01% | 4448 |
|
|
2023
Q1 | $558K | Buy |
60,391
+59,695
| +8,577% | +$549K | ﹤0.01% | 4427 |
|
|
2022
Q4 | $6K | Sell |
696
-51,982
| -99% | -$492K | ﹤0.01% | 6136 |
|
|
2022
Q3 | $438K | Buy |
52,678
+38,619
| +275% | +$319K | ﹤0.01% | 4550 |
|
|
2022
Q2 | $116K | Sell |
14,059
-67,808
| -83% | -$466K | ﹤0.01% | 5340 |
|
|
2022
Q1 | $714K | Buy |
81,867
+19,280
| +31% | +$150K | ﹤0.01% | 4478 |
|
|
2021
Q4 | $595K | Sell |
62,587
-2,426
| -4% | -$34.2K | ﹤0.01% | 4714 |
|
|
2021
Q3 | $1.09M | Sell |
65,013
-20,719
| -24% | -$328K | ﹤0.01% | 4244 |
|
|
2021
Q2 | $1.31M | Sell |
85,732
-12,425
| -13% | -$225K | ﹤0.01% | 4113 |
|
|
2021
Q1 | $1.91M | Buy |
98,157
+13,175
| +16% | +$280K | ﹤0.01% | 3758 |
|
|
2020
Q4 | $1.53M | Sell |
84,982
-17,676
| -17% | -$370K | ﹤0.01% | 3676 |
|
|
2020
Q3 | $1.98M | Sell |
102,658
-10,379
| -9% | -$235K | ﹤0.01% | 3244 |
|
|
2020
Q2 | $2.95M | Sell |
113,037
-17,411
| -13% | -$426K | ﹤0.01% | 2849 |
|
|
2020
Q1 | $2.33M | Sell |
130,448
-13,494
| -9% | -$365K | ﹤0.01% | 2855 |
|
|
2019
Q4 | $4.8M | Buy |
143,942
+124,924
| +657% | +$3.41M | ﹤0.01% | 2708 |
|
|
2019
Q3 | $453K | Buy |
19,018
+13,872
| +270% | +$454K | ﹤0.01% | 4222 |
|
|
2019
Q2 | $170K | Buy |
+5,146
| New | +$190K | ﹤0.01% | 4725 |
|
|
2018
Q4 | – | Sell |
-6,778
| Closed | -$320K | – | 5963 |
|
|
2018
Q3 | $320K | Buy |
+6,778
| New | +$315K | ﹤0.01% | 4499 |
|
|
2018
Q2 | – | Sell |
-2,073
| Closed | -$103K | – | 5706 |
|
|
2018
Q1 | $103K | Sell |
2,073
-2,887
| -58% | -$145K | ﹤0.01% | 4578 |
|
|
2017
Q4 | $185K | Sell |
4,960
-211
| -4% | -$7.51K | ﹤0.01% | 4447 |
|
|
2017
Q3 | $168K | Buy |
+5,171
| New | +$114K | ﹤0.01% | 4153 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
